Why Is AbbVie Inc. (ABBV) Stock Up Today?
AI-sourced movement explanations, refreshed three times each trading day · Latest: October 15, 2026
AbbVie posts slight gain, underperforms sector on quiet trading day
The Full Story
AbbVie (ABBV) saw a modest increase of 0.1129% in its stock price today, closing at $283.33. This marginal gain, however, lagged behind the broader sector, which experienced an average change of +0.91%. The provided news did not indicate any specific catalysts driving today's price movement, suggesting a relatively quiet trading session for the pharmaceutical giant.
What's Driving the Move
Modest Price Movement
AbbVie experienced a slight increase in its stock price, but this was less than the average gain seen across its sector, indicating a relatively subdued trading day without specific company-driven catalysts.
Significant Moves — Last 90 Days
AbbVie Outperforms Sector Amid Strong Investor Attention
Previous Sessions
A running log of what moved ABBV each trading day.
| Date | Move | What Happened |
|---|---|---|
| Oct 14 | ▲ +3.50% | AbbVie Outperforms Sector Amid Strong Investor Attention |
| Oct 13 | ▼ -2.40% | AbbVie (ABBV) declines, underperforming healthcare sector |
| Oct 12 | ▲ +1.68% | AbbVie Jumps on Dual FDA Breakthrough Therapy Tags for Cancer Drug |
| Oct 9 | ▲ +1.21% | AbbVie Rises on Positive Oncology Pipeline Developments |
| Oct 8 | ▲ +0.39% | AbbVie Rises on Positive Cancer Drug Developments, Outperforming Sector |
| Oct 7 | ▲ +2.29% | AbbVie Rises on Positive Epcoritamab Trial Results |
| Oct 6 | ▲ +0.35% | AbbVie Posts Modest Gain on Positive Clinical Trial Data |
| Oct 5 | ▲ +0.83% | AbbVie Rises on Positive Clinical Trial Results for Epcoritamab |
| Oct 2 | ▲ +1.20% | AbbVie (ABBV) Rises, Outperforming Sector on Positive News |
| Oct 1 | ▼ -0.43% | ABBV Dips Slightly, Outperforming a Weaker Sector |
| Sep 30 | ▼ -0.52% | AbbVie Outperforms Sector on Positive Drug News Despite Modest Decline |
| Sep 29 | ▼ -1.12% | AbbVie shares dip amid higher rate concerns, overshadowing FDA nod |
| Sep 28 | ▲ +0.73% | AbbVie Outperforms Sector Amidst Positive Autoimmune Market Outlook |
| Sep 25 | ▼ -0.29% | AbbVie Experiences Slight Dip, Underperforms Sector |
Frequently Asked Questions
Why is ABBV stock up today?
How do you determine why a stock moved?
When is this page updated?
What counts as a significant move?
Methodology
Each trading day we pair ABBV’s price and volume action with same-day news coverage, earnings events, analyst actions, and sector context, then generate a sourced explanation using AI with live search grounding. Updates run shortly after the open, midday, and after the close — intraday versions are marked preliminary.
Moves are flagged significant based on their size relative to the stock’s typical daily range. Explanations describe what plausibly drove a move; markets don’t always have a single clean cause.
Not Financial Advice
This page is for education and information only. Indicators are mechanical calculations, AI commentary can contain errors, and nothing here is a recommendation to buy or sell any security. Do your own research and consider consulting a qualified financial advisor. See our full disclaimer.
Keep Digging on ABBV
AbbVie Inc. Overview
Price, chart, analysis & financials
ABBV: Overbought or Oversold?
Updated daily
ABBV: Price Prediction
Updated daily
ABBV: Undervalued or Overvalued?
Updated daily
Same question, Healthcare peers